FHI vs CNS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 28, 2026
FHI
CNS
Investment Advisor Scores
CNS
Sep 28, 2026AI Analyst Insights
Detailed Metrics Comparison
| Metric | FHI | CNS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 9.9206 | 18.4502 | FHI |
| PEG Ratio | 1.3978 | 1.6881 | FHI |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 18.3% | 12.2% | FHI |
| Earnings Growth | 19.3% | 31.9% | CNS |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 61.6/100 | 67.8/100 | CNS |
| Profit Margin | 21.3% | 28.8% | CNS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
| Implied Volatility | N/A | N/A | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
FHI
NeutralMixed signals - no dominant trend phase, RSI 40
CNS
MarkdownPrice below a falling SMA50 (slope -0.5%), weak momentum, RSI 39
Fundamentals Snapshot
| Metric | FHI | CNS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.8 | 18.6 |
| Trailing P/E | 10.7 | 23.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.1% |
| Gross Margin | 0.7% | 0.5% |
| Operating Margin | 0.3% | 0.3% |
| EPS | 5.37 | 3.24 |
| Dividend Yield | 0.02% | 0.03% |